TaiMed Biologics

Last updated: 13.02.2014

Address: 18201 Von Karman Ave, Suite 470. Irvine, CA 92612

Tel: (949) 769-6543

Web: http://www.taimedbiologics.com/

Company description

TaiMed Biologics was formed on September 4, 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy the unmet medical needs of patients around the world.

Products and services

The company signed an agreement with Genentech for the licensing of Ibalizumab shortly after its formation. This drug candidate, also known as TMB-355, is a proprietary humanized anti-CD4 monoclonal antibody for the treatment of HIV/AIDS. A phase-2b clinical trial is currently underway and the coma expect the trial to be completed in Q1 2011.


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here